Intensive BP, combined lipid therapies do not help adults with diabetes
Sunday, March 14, 2010 - 08:56
in Health & Medicine
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial. Similarly, treating multiple blood lipids with combination drug therapy of a fibrate and a statin did not reduce the combined risk of cardiovascular disease events more than treatment with statin alone. The study of more than 10,000 participants is sponsored by the National Institutes of Health.
Read the whole article on Physorg
More from Physorg
Related
- ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetesSun, 14 Mar 2010, 9:37:52 EDT
- ACCORD clinical trial publishes resultsFri, 6 Jun 2008, 17:35:45 EDT
- Can diabetes or lipid-lowering medications treat addiction?Tue, 5 Apr 2011, 18:33:20 EDT
- Evidence poor for link between biomarkers and risk of CV events for patients with kidney diseaseTue, 15 Mar 2011, 17:35:06 EDT
- Aspirin appears to help lower risk of stroke for patients with peripheral artery diseaseTue, 12 May 2009, 17:09:55 EDT